TINF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.546100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.092100E-02
Normal-vs-Stage2
1.807940E-02
Normal-vs-Stage3
7.218200E-02
Normal-vs-Stage4
5.712000E-01
Stage1-vs-Stage2
7.404000E-01
Stage1-vs-Stage3
4.268600E-01
Stage1-vs-Stage4
4.243600E-01
Stage2-vs-Stage3
2.499000E-01
Stage2-vs-Stage4
1.836990E-01
Stage3-vs-Stage4
2.609000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.696300E-02
Normal-vs-AfricanAmerican
1.781580E-01
Normal-vs-Asian
2.039800E-02
Caucasian-vs-AfricanAmerican
8.189800E-01
Caucasian-vs-Asian
1.120210E-01
AfricanAmerican-vs-Asian
2.887400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.780000E-02
Normal-vs-Female
4.715600E-02
Male-vs-Female
1.774020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.728590E-01
Normal-vs-Age(41-60Yrs)
6.203800E-02
Normal-vs-Age(61-80Yrs)
1.848470E-02
Normal-vs-Age(81-100Yrs)
2.314200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.346200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.524800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.637800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.339650E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.607200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.432200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.483760E-02
Normal-vs-Daily Drinker
3.669900E-02
Normal-vs-Weekly Drinker
6.532000E-02
Normal-vs-Occasional Drinker
1.228770E-01
Normal-vs-Social Drinker
5.162300E-02
Non Drinker-vs-Daily Drinker
3.165000E-01
Non Drinker-vs-Weekly Drinker
5.387800E-01
Non Drinker-vs-Occasional Drinker
5.370300E-02
Non Drinker-vs-Social Drinker
1.575580E-01
Daily Drinker-vs-Weekly Drinker
8.352400E-01
Daily Drinker-vs-Occasional Drinker
3.136200E-01
Daily Drinker-vs-Social Drinker
6.103000E-01
Weekly Drinker-vs-Occasional Drinker
3.040000E-01
Weekly Drinker-vs-Social Drinker
5.322600E-01
Occasional Drinker-vs-Social Drinker
6.287200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.139200E-01
Normal-vs-Grade 2
7.247200E-01
Normal-vs-Grade 3
7.024000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.047400E-01
Grade 1-vs-Grade 3
6.718800E-01
Grade 1-vs-Grade 4
4.139200E-01
Grade 2-vs-Grade 3
5.622600E-01
Grade 2-vs-Grade 4
7.247200E-01
Grade 3-vs-Grade 4
7.024000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.361600E-02
Normal-vs-NonDiabetic
1.528030E-02
Diabetic-vs-NonDiabetic
9.895400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.721500E-03
Normal-vs-NoPancreatitis
2.484300E-02
Pancreatitis-vs-NoPancreatitis
1.304640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.585700E-02
Normal-vs-N1
2.730100E-02
N0-vs-N1
4.814800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.671900E-02
Normal-vs-TP53-NonMutant
6.845900E-02
TP53-Mutant-vs-TP53-NonMutant
9.396000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
